{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:53:57Z","timestamp":1784105637685,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000940","name":"Arthritis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.semarthrit.2020.05.015","type":"journal-article","created":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T06:08:32Z","timestamp":1590818912000},"page":"719-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group"],"prefix":"10.1016","volume":"50","author":[{"given":"Ken","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Hensey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Grossberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder A.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semarthrit.2020.05.015_bib0001","first-page":"819","article-title":"Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study","volume":"23","author":"Salaffi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.05.015_bib0002","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/0003-4819-56-5-711","article-title":"The significance of calcium pyrophosphate crystals in the synovial fluid of arthritic patients: the \u201cpseudogut syndrome.\u201d 1. Clinical aspects","volume":"56","author":"McCarty D Jr","year":"1962","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.05.015_bib0003","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/ard.2010.139105","article-title":"European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semarthrit.2020.05.015_bib0004","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.05.015_bib0005","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/annrheumdis-2017-212542","volume":"77","author":"Filippou","year":"2018","journal-title":"Ann Rheumatic Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.05.015_bib0006","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3899\/jrheum.161057","article-title":"Definition and reliability assessment of elementary ultrasonographic findings in calcium pyrophosphate deposition disease: a study by the OMERACT calcium pyrophosphate deposition disease ultrasound Subtask Force","volume":"44","author":"Filippou","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.05.015_bib0007","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019): Cochrane; 2019.","DOI":"10.1002\/9781119536604"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.05.015_bib0008","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.05.015_bib0009","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3899\/jrheum.181096","article-title":"OMERACT Filter 2.1: elaboration of the conceptual framework for outcome measurement in health intervention studies","volume":"46","author":"Boers","year":"2019","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.05.015_bib0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/RHU.0b013e3182611471","article-title":"Methotrexate is an option for patients with refractory calcium pyrophosphate crystal arthritis","volume":"18","author":"Andres","year":"2012","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.05.015_bib0011","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.22389","article-title":"Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis","volume":"56","author":"Chollet-Janin","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.05.015_bib0012","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13075-014-0458-4","article-title":"Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial","volume":"16","author":"Finckh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.05.015_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/792173","article-title":"Efficacy of anakinra for various types of crystal-induced arthritis in complex hospitalized patients: a case series and review of the literature","volume":"2015","author":"Aouba","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.05.015_bib0014","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jbspin.2012.01.010","article-title":"Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis","volume":"79","author":"Molto","year":"2012","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.05.015_bib0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jbspin.2012.07.018","article-title":"Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature","volume":"80","author":"Ottaviani","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.05.015_bib0016","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10067-018-4272-2","article-title":"Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases","volume":"38","author":"Thomas","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.015_bib0017","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jbspin.2013.05.006","article-title":"ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients","volume":"81","author":"Daoussis","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.05.015_bib0018","first-page":"696","article-title":"ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems","volume":"21","author":"Ritter","year":"1994","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.05.015_bib0019","first-page":"1168","article-title":"Prospective use of intramuscular triamcinolone acetonide in pseudogout","volume":"24","author":"Roane","year":"1997","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.05.015_bib0020","first-page":"327","article-title":"Yakubov LE. Prospective 6-month, double-blind trial of hydroxychloroquine treatment of CPDD","volume":"23","author":"Rothschild","year":"1997","journal-title":"Compr Ther"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.05.015_bib0021","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/pho.2006.24.140","article-title":"Photobiomodulation of pain and inflammation in microcrystalline arthropathies: experimental and clinical results","volume":"24","author":"Soriano","year":"2006","journal-title":"Photomed Laser Surg"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.015_bib0022","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.1780190116","article-title":"Crystal shedding and acute pseudogout. An hypothesis based on a therapeutic failure","volume":"19","author":"Bennett","year":"1976","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.05.015_bib0023","article-title":"There is no difference in postoperative pain, function and complications in patients with chondrocalcinosis in the outcome of total knee arthroplasty for end-stage osteoarthritis","author":"Willems","year":"2019","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.05.015_bib0024","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/acr.21952","article-title":"Evidence of a systemic predisposition to chondrocalcinosis and association between chondrocalcinosis and osteoarthritis at distant joints: a cross-sectional study","volume":"65","author":"Abhishek","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.05.015_bib0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jbspin.2015.01.011","article-title":"Hospital burden of gout, pseudogout and other crystal arthropathies in France","volume":"82","author":"Maravic","year":"2015","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.015_bib0026","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7150\/jbji.29983","article-title":"Clinical presentation, management, and prognosis of pseudogout in joint arthroplasty: a retrospective cohort study","volume":"4","author":"George","year":"2019","journal-title":"J Bone Jt Infect"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.05.015_bib0027","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/32.3.189","article-title":"Pyrophosphate arthropathy: a prospective study","volume":"32","author":"Doherty","year":"1993","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.015_bib0028","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3171\/SPI-08\/01\/022","article-title":"Calcium pyrophosphate dihydrate crystal deposition in the craniovertebral junction","volume":"8","author":"Fenoy","year":"2008","journal-title":"J Neurosurg Spine"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.015_bib0029","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1227\/01.NEU.0000068861.47199.A8","article-title":"Tumoral calcium pyrophosphate dihydrate deposition disease of the ligamentum flavum","volume":"53","author":"Muthukumar","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.semarthrit.2020.05.015_bib0030","first-page":"142","article-title":"Chondrocalcinosis articularis Section L Clinical and radiological study","volume":"22","author":"Zitnan","year":"1963","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.05.015_bib0031","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.090370","article-title":"Outcome domains for studies of acute and chronic gout","volume":"36","author":"Schumacher","year":"2009","journal-title":"J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:03:55Z","timestamp":1758733435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220301463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0049017220301463"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.015","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}